Gabelli Global Financial Services Fund (GFSIX) Surpasses $100M in Assets

Gabelli Global Financial Services Fund (GFSIX) Surpasses $100M in Assets GlobeNewswire December 22, 2025 GREENWICH, Conn., Dec. 22, 2025 (GLOBE NEWSWIRE) — The Gabelli Global Financial Services Fund (GFSIX) has surpassed $100M in assets under management (AUM), reflecting increasing investor participation and strong fund performance. Since its inception in 2018, GFSIX has been managed by […]

Statement on new EU choline chloride anti-dumping measures

Statement on new EU choline chloride anti-dumping measures EU producers laud EU for addressing choline chloride dumping by China; measures will help preserve jobs and secure feed supply chain GlobeNewswire December 22, 2025 MONTVALE, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) — As producers of choline chloride in the EU, Eastman and Balchem welcome the European

CoRegen Appoints Globally Recognized Surgeon-Scientist Bert O’Malley Jr. to its Board of Directors

CoRegen Appoints Globally Recognized Surgeon-Scientist Bert O'Malley Jr. to its Board of Directors GlobeNewswire December 22, 2025 HOUSTON, Dec. 22, 2025 (GLOBE NEWSWIRE) — CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of solid tumor cancer, today announced the appointment of Bert W. O'Malley, Jr.,

RESTEM to Present Company Overview in Biotech Showcase 2026

RESTEM to Present Company Overview in Biotech Showcase 2026 GlobeNewswire December 22, 2025 MIAMI, Dec. 22, 2025 (GLOBE NEWSWIRE) — RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced its participation in Biotech Showcase 2026, to be held on January 12-14, 2026, in San

Tree Island Announces Appointment of Guy Elliott to Board of Directors

Tree Island Announces Appointment of Guy Elliott to Board of Directors GlobeNewswire December 22, 2025 VANCOUVER, British Columbia, Dec. 22, 2025 (GLOBE NEWSWIRE) — Tree Island Steel Ltd. (the “Company” or “Tree Island Steel“) (TSX: TSL) today announced the addition of Guy Elliott as an independent director joining the Company's board of directors (the “Board“)

INVESTOR ALERT: Class Action Lawsuit Filed on Coupang, Inc. (CPNG) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

INVESTOR ALERT: Class Action Lawsuit Filed on Coupang, Inc. (CPNG) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm GlobeNewswire December 22, 2025 ATLANTA, Dec. 22, 2025 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against Coupang, Inc. (“Coupang” or the “Company”) (NYSE: CPNG). The lawsuit

Rectify and Boehringer Ingelheim Collaborate to Advance First-in-class Treatments for Chronic Kidney Disease

Rectify and Boehringer Ingelheim Collaborate to Advance First-in-class Treatments for Chronic Kidney Disease GlobeNewswire December 22, 2025 Collaboration aims to accelerate the development of treatments for chronic kidney disease (CKD) and other conditions Rectify has developed oral, small molecules that can potentially reduce calcification by enhancing the activity of the ABCC6 protein, a key disease

Tokyo Lifestyle Co., Ltd. Announces Payment of Interim Dividend for Fiscal Year 2026

Tokyo Lifestyle Co., Ltd. Announces Payment of Interim Dividend for Fiscal Year 2026 GlobeNewswire December 22, 2025 Tokyo, Japan, Dec. 22, 2025 (GLOBE NEWSWIRE) — Tokyo Lifestyle Co., Ltd. (“Tokyo Lifestyle” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic products, collectible cards, trendy

Par Pacific Announces 2026 Capital Expenditure Guidance

Par Pacific Announces 2026 Capital Expenditure Guidance GlobeNewswire December 22, 2025 HOUSTON, Dec. 22, 2025 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced its 2026 capital expenditure and turnaround outlay guidance with a range of $190 million to $220 million. 2026 Capital Expenditure and Turnaround Outlay Guidance $ in millions

DemandScience Earns Top Rankings in G2 Winter 2026 Reports

DemandScience Earns Top Rankings in G2 Winter 2026 Reports DemandScience recognized with 26 badges and #1 Enterprise rankings across Account-Based Orchestration and Web Experiences GlobeNewswire December 22, 2025 DANVERS, MA, Dec. 22, 2025 (GLOBE NEWSWIRE) — DemandScience, a global leader in Precision Performance Marketing, today announced strong performance in the G2 Winter 2026 Reports, earning

Scroll to Top